Gross, O.
(2023).
 SGLT2 Inhibitors are Blockbusters in Adults - But Not Studied in Children with Kidney Disease due to Industry Conflicts of Commercial Interest: A Call for Help To Regulators.
<em>Medical Research Archives, 11</em>(8).
doi:10.18103/mra.v11i8.4383